Russell Warnick

1.8k total citations · 2 hit papers
7 papers, 1.3k citations indexed

About

Russell Warnick is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Russell Warnick has authored 7 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Russell Warnick's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Russell Warnick is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Russell Warnick collaborates with scholars based in United States and Denmark. Russell Warnick's co-authors include Alan T. Remaley, Melissa J. Contos, Faridoddin Mirshahi, Ashwani Kapoor, Hae‐Ki Min, James W. Maher, Arun J. Sanyal, Michael Fuchs, John M. Kellum and Huiping Zhou and has published in prestigious journals such as Cell Metabolism, Arteriosclerosis Thrombosis and Vascular Biology and Clinical Chemistry.

In The Last Decade

Russell Warnick

7 papers receiving 1.3k citations

Hit Papers

Increased Hepatic Synthesis and Dysregulation of Choleste... 2012 2026 2016 2021 2012 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
    2012 517 citations Hae‐Ki Min, Ashwani Kapoor et al. Cell Metabolism profile →
  2. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
    2020 312 citations Maureen Sampson, Qian Sun et al. JAMA Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell Warnick United States 7 740 644 451 297 258 7 1.3k
Yassine Zaïr France 20 762 1.0× 487 0.8× 373 0.8× 172 0.6× 202 0.8× 34 1.5k
Ye‐Xuan Cao China 22 759 1.0× 580 0.9× 321 0.7× 633 2.1× 197 0.8× 69 1.5k
Roberto Scicali Italy 22 350 0.5× 474 0.7× 339 0.8× 264 0.9× 134 0.5× 51 1.2k
Marcelo Costa Batista Brazil 19 523 0.7× 449 0.7× 217 0.5× 222 0.7× 170 0.7× 69 1.3k
Jing‐Lu Jin China 21 616 0.8× 502 0.8× 305 0.7× 551 1.9× 139 0.5× 54 1.2k
Christina Kostara Greece 19 334 0.5× 417 0.6× 266 0.6× 213 0.7× 140 0.5× 52 1.3k
Anna Montali Italy 23 561 0.8× 532 0.8× 252 0.6× 545 1.8× 282 1.1× 50 1.5k
Christos V. Rizos Greece 19 392 0.5× 601 0.9× 181 0.4× 165 0.6× 128 0.5× 42 1.3k
Kashif Jafri United States 10 968 1.3× 862 1.3× 237 0.5× 374 1.3× 300 1.2× 13 1.9k
B Angelin Sweden 22 943 1.3× 576 0.9× 233 0.5× 275 0.9× 254 1.0× 28 1.7k

Countries citing papers authored by Russell Warnick

Since Specialization
Citations

This map shows the geographic impact of Russell Warnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Warnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Warnick more than expected).

Fields of papers citing papers by Russell Warnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Warnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Warnick. The network helps show where Russell Warnick may publish in the future.

Co-authorship network of co-authors of Russell Warnick

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Warnick. A scholar is included among the top collaborators of Russell Warnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Warnick. Russell Warnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sampson, Maureen, Anna Wolska, Russell Warnick, Diego Lucero, & Alan T. Remaley. (2021). A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test. Clinical Chemistry. 67(7). 987–997. 64 indexed citations
2.
Sampson, Maureen, Qian Sun, Roa Harb, et al.. (2020). A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiology. 5(5). 540–540. 312 indexed citations breakdown →
3.
Cao, Jing, Brian T. Steffen, Matthew J. Budoff, et al.. (2016). Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals. Arteriosclerosis Thrombosis and Vascular Biology. 36(5). 1003–1009. 64 indexed citations
4.
Guan, Weihua, Jing Cao, Brian T. Steffen, et al.. (2015). Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment. Arteriosclerosis Thrombosis and Vascular Biology. 35(4). 996–1001. 143 indexed citations
5.
Tsai, Michael Y., Brian T. Steffen, Weihua Guan, et al.. (2013). New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease. Arteriosclerosis Thrombosis and Vascular Biology. 34(1). 196–201. 131 indexed citations
6.
Min, Hae‐Ki, Ashwani Kapoor, Michael Fuchs, et al.. (2012). Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease. Cell Metabolism. 15(5). 665–674. 517 indexed citations breakdown →
7.
Sethi, Amar A, Maureen Sampson, Russell Warnick, et al.. (2010). High Pre-β1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol. Clinical Chemistry. 56(7). 1128–1137. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yassine Zaïr Breakdown of academic impact, for papers by Ye‐Xuan Cao Breakdown of academic impact, for papers by Roberto Scicali Breakdown of academic impact, for papers by Marcelo Costa Batista Breakdown of academic impact, for papers by Jing‐Lu Jin Breakdown of academic impact, for papers by Christina Kostara Breakdown of academic impact, for papers by Anna Montali Breakdown of academic impact, for papers by Christos V. Rizos Breakdown of academic impact, for papers by Kashif Jafri Breakdown of academic impact, for papers by B Angelin
Rankless by CCL
2026